Bruker completed the acquisition of Biocrates.

Bruker, an American manufacturer of scientific instruments for molecular and materials research, completed the acquisition of Biocrates, an Austrian biotechnology company focused on targeted metabolomics. Financial terms were not disclosed. "With Bruker we are poised to scale our impact while staying true to our mission to make omics quantitative, reproducible and easily accessible. We are deeply thankful to our employees, customers, and partners who made this possible," Moritz Seuster, Biocrates CEO.